Most popular

Will Dr Reddy share go up?

Will Dr Reddy share go up?

Will Dr. Reddy`s Laboratories stock price grow / rise / go up? Yes. The Drreddys Laboratories Ltd stock price can go up from 4516.850 INR to 5714.020 INR in one year.

Is Dr Reddy share overvalued?

The stock of Dr Reddy’s Laboratories (NYSE:RDY, 30-year Financials) gives every indication of being significantly overvalued, according to GuruFocus Value calculation. At its current price of $63.08 per share and the market cap of $10.5 billion, Dr Reddy’s Laboratories stock appears to be significantly overvalued.

Can we buy Dr Reddy share?

Advising short-term investors to buy Dr. Reddy’s shares; Sumeet Bagadia, Executive Director at Choice Broking said, “One can initiate momentum buy at current market price for immediate short-term target of ₹5050 to ₹5200 maintaining stop loss at ₹4800.”

READ ALSO:   Does Cathay Pacific check carry on baggage weight?

Why is Drreddy’s share falling?

“This fall in Dr Reddy’s Lab share price is mainly due to the fall in profit in recently ended June 2021 quarter. The market was expecting huge rise in its profit but the company has reported a fall which has come as huge disappointment for the market,” Gorakshkar added.

What is the target of Dr Reddy share?

Reddy’s Laboratories with a target price of Rs 5600. The current market price of Dr. Reddy’s Laboratories is Rs 4730.1.

Who owns Dr Reddy’s?

Kallam Anji Reddy (1 February 1939 – 15 March 2013) was an Indian entrepreneur in the pharmaceutical industry, the founder-chairman of Dr. Reddy’s Laboratories, which he established in 1984, and chairman of Dr Reddy’s Foundation (DRF), the corporate social responsibility arm of the group, established 1996.

Is Dr Reddy a debt free company?

Debt Level: 500124’s net debt to equity ratio (1.4\%) is considered satisfactory….Debt to Equity History and Analysis.

READ ALSO:   What does Apple look for in engineers?
Sep 29 2021
equity ₹183.928b 14.8\%

What does Dr Reddy do?

Dr. Reddy’s manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology products. Dr.

https://www.youtube.com/watch?v=ICuHm6AyNgg